Literature DB >> 7831964

Fine mechanisms of ectromelia virus thymidine kinase-negative mutants avirulence.

G V Kochneva1, I H Urmanov, E I Ryabchikova, V V Streltsov, O I Serpinsky.   

Abstract

Three independently selected spontaneous thymidine kinase-negative mutants (TK-phenotype) and a recombinant with Escherichia coli beta-galactosidase gene (LacZ+ phenotype) inserted in the viral thymidine kinase gene (tk) were derived from a plaque-cloned isolate of K-1 ectromelia virus strain (TK+ phenotype). Dramatically decreased virulence of TK- variants was observed for all routes of mouse inoculation. The kinetics of TK+ and TK- variants in various target organs indicated a significant decrease of production and dissemination of TK- mutants and recombinant in the organs of mice. In the spleen and liver of intranasally or intracerebrally infected mice TK- virus was not detected during the entire period of observation. Analysis of organs homogenates of mice intranasally infected by a mixture of recombinant with TK-LacZ+ phenotype and parental isolate with TK+LacZ- phenotype on the monolayers of TK- cells indicated that only white plaques (LacZ-) with the TK+ phenotype appeared from liver and spleen homogenates. Thus, the mouse acts as a live filter much more efficiently than any other selective systems. Ultrastructural studies showed that viral damage in animals infected by TK- variants was far less than that observed in mice, infected with wild type of ectromelia virus and pathological lessions were slight and reversible. Replication of ectromelia virus TK- variants was blocked at the viroplasma stage in cells with a high level of differentiation in contrast to TK+ variants. Most likely, such restriction of target cells assortment is the general reason of reduced virulence in the case of tk-gene inactivation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7831964     DOI: 10.1016/0168-1702(94)90118-x

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  6 in total

1.  Viral Replicative Capacity, Antigen Availability via Hematogenous Spread, and High TFH:TFR Ratios Drive Induction of Potent Neutralizing Antibody Responses.

Authors:  Preethi Eldi; Geeta Chaudhri; Stephen L Nutt; Timothy P Newsome; Gunasegaran Karupiah
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

Authors:  R J Jackson; A J Ramsay; C D Christensen; S Beaton; D F Hall; I A Ramshaw
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Protective effect of exogenous recombinant mouse interferon-gamma and tumour necrosis factor-alpha on ectromelia virus infection in susceptible BALB/c mice.

Authors:  A V Atrasheuskaya; E K Bukin; T M Fredeking; G M Ignatyev
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

4.  The African swine fever virus thymidine kinase gene is required for efficient replication in swine macrophages and for virulence in swine.

Authors:  D M Moore; L Zsak; J G Neilan; Z Lu; D L Rock
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

5.  Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination.

Authors:  Daniel Byrd; Nicole Shepherd; Jie Lan; Ningjie Hu; Tohti Amet; Kai Yang; Mona Desai; Qigui Yu
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

6.  A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.

Authors:  Ali Alejo; Margarida Saraiva; Maria Begoña Ruiz-Argüello; Abel Viejo-Borbolla; Mar Fernández de Marco; Francisco Javier Salguero; Antonio Alcami
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.